Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe

BACKGROUND: The reimbursement of orphan drugs (OD) is an increasingly important for country policymakers, and still insufficiently understood, especially in Central and Eastern Europe. The aim of this research was to provide a comprehensive description of country-specific health technology assessmen...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Orphanet J Rare Dis
Autors principals: Malinowski, Krzysztof Piotr, Kawalec, Paweł, Trąbka, Wojciech, Sowada, Christoph, Petrova, Guenka, Manova, Manoela, Savova, Alexandra, Draganić, Pero, Slabý, Juraj, Männik, Agnes, Márky, Kristóf, Rugaja, Zinta, Gulbinovic, Jolanta, Tesar, Tomas, Paveliu, Marian Sorin
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7545889/
https://ncbi.nlm.nih.gov/pubmed/33032634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-020-01556-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars